Related Experiment Video
Updated: Aug 8, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
TGN1412: time to change the paradigm for the testing of new pharmaceuticals
Nirmala Bhogal1, Robert Combes
1FRAME, 96-98 North Sherwood Street, Nottingham, NG1 4EE, UK. Nirmala@frame.org.uk
Abstract:
Clinical studies in human volunteers are an essential part of drug development. These studies are designed to account for possible differences between the effects of pharmaceutical products in preclinical studies and in humans. However, the tragic outcome of the recent Phase 1 clinical trial on TGN1412 casts considerable doubt over the relevance of this traditional drug development paradigm to the testing of therapeutic agents for human use. The role of alternatives to animal testing is considered, and a series of recommendations are made, which could ensure that clinical trials are well informed and based on the most relevant scientific information.
Related Concept Videos
Clinical Trials: Overview
Preclinical Development: Overview
Pharmacogenomics: Identification of New Drug Targets
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug Discovery: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...

